John Rickard

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

Bundle-Branch Block Morphology and Other Predictors of Outcome After Cardiac Resynchronization Therapy in Medicare Patients

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

Transvenous Extraction of Pacemaker and Defibrillator Leads and the Risk of Tricuspid Valve Regurgitation

Obesity and Kidney Disease: Hidden Consequences of the Epidemic

Effect of QRS morphology on clinical event reduction with cardiac resynchronization therapy: Meta-analysis of randomized controlled trials

Safety and effectiveness of bariatric surgery in dialysis patients and kidney transplantation candidates

Cardiac resynchronization therapy in patients with left ventricular systolic dysfunction and right bundle branch block: A systematic review

Cardiac Implantable Electronic Device Lead-Induced Tricuspid Regurgitation

Windows into human health through wearables data analytics

An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure

End-to-end design of wearable sensors

Cancer drugs and the heart: importance and management

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death

Impact of QRS Morphology and Duration on Outcomes After Cardiac Resynchronization Therapy

2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation

2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Cardiac resynchronisation therapy is not associated with a reduction in mortality or heart failure hospitalisation in patients with non-left bundle branch block QRS morphology: meta-analysis of randomised controlled trials

Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy

2012 ACCF/AHA/HRS Focused Update of the 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

Predictors of Response to Cardiac Resynchronization Therapy in Patients With a Non-Left Bundle Branch Block Morphology

Cardiac Resynchronization Therapy in Non-Left Bundle Branch Block Morphologies

Transvenous lead extraction at the time of cardiac implantable electronic device upgrade: Complexity, safety, and outcomes

QRS prolongation induced by cardiac resynchronization therapy correlates with deterioration in left ventricular function

Cardiac Resynchronization Therapy in CKD

Differential Response to Cardiac Resynchronization Therapy and Clinical Outcomes According to QRS Morphology and QRS Duration

Assessing the accuracy of an automated atrial fibrillation detection algorithm using smartphone technology: The iREAD Study

Usefulness of Cardiac Resynchronization Therapy in Patients With Adriamycin-Induced Cardiomyopathy

Extraction of Implantable Cardiac Electronic Devices